Norovirus vaccine: Oral tablet Phase 1 clinical trial results published
by Press Release from Outbreak News Today on (#3TTR0)
Vaxart, Inc. a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced publication of the comprehensive results of the previously disclosed Phase 1 clinical trial with its norovirus oral tablet vaccine in the Journal of Clinical Investigation Insight. The paper by Leesun, Kim, et al., "Safety and immunogenicity ["]
The post Norovirus vaccine: Oral tablet Phase 1 clinical trial results published appeared first on Outbreak News Today.